Most American hospital patients are given drugs not approved by the U.S. Food and Drug Administration for the prescribed use. If off-label prescribing is so widespread and successful, is the FDAs pre-approval process really necessary?
Assessing the FDA via the Anomaly of Off-Label Drug Prescribing
By Alexander T. Tabarrok
This
article
appeared in
the Summer 2000 issue of The Independent Review.
Other Independent Review articles by Alexander T. Tabarrok | ||
Fall 2019 | Premature Imitation and Indias Flailing State | |
Fall 2013 | The Global Organ Shortage: Economic Causes, Human Consequences, Policy Responses | |
Spring 2007 | The Rise, Fall, and Rise Again of Privateers | |
[View All (5)] |